The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed. 2015

Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
Institute for Glycomics, Gold Coast Campus, Griffith University, Queensland, 4222 (Australia).

Human parainfluenza virus type 3 (hPIV-3) is one of the leading causes for lower respiratory tract disease in children, with neither an approved antiviral drug nor vaccine available to date. Understanding the catalytic mechanism of human parainfluenza virus haemagglutinin-neuraminidase (HN) protein is key to the design of specific inhibitors against this virus. Herein, we used (1) H NMR spectroscopy, X-ray crystallography, and virological assays to study the catalytic mechanism of the HN enzyme activity and have identified the conserved Tyr530 as a key amino acid involved in catalysis. A novel 2,3-difluorosialic acid derivative showed prolonged enzyme inhibition and was found to react and form a covalent bond with Tyr530. Furthermore, the novel derivative exhibited enhanced potency in virus blockade assays relative to its Neu2en analogue. These outcomes open the door for a new generation of potent inhibitors against hPIV-3 HN.

UI MeSH Term Description Entries
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010224 Parainfluenza Virus 3, Human A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia. Hemadsorption Virus 1,Human parainfluenza virus 3,Para-Influenza Virus Type 3,Parainfluenza Virus Type 3,Para Influenza Virus Type 3
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D019267 Hemagglutinin Glycoproteins, Influenza Virus Membrane glycoproteins from influenza viruses which are involved in hemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of HA glycoproteins and nine of NA glycoproteins have been identified from INFLUENZA A VIRUS; no subtypes have been identified for Influenza B or Influenza C viruses.
D066244 Proton Magnetic Resonance Spectroscopy Spectroscopy technique which measures changes in organic compounds by tracking the spectral energy of absorption of HYDROGEN atoms. 1H NMR,1H-MRS,1H-NMR

Related Publications

Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
January 2004, Journal of molecular biology,
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
June 1995, Epidemiology and infection,
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
November 2015, Antiviral research,
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
April 1988, The Journal of general virology,
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
December 1994, The Journal of general virology,
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
June 1985, Virology,
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
April 1971, The Journal of general virology,
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
October 1981, Infection and immunity,
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
January 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Larissa Dirr, and Ibrahim M El-Deeb, and Patrice Guillon, and Cindy J Carroux, and Leonard M G Chavas, and Mark von Itzstein
January 1975, Developments in biological standardization,
Copied contents to your clipboard!